Pharmacology of Airway Goblet Cell Mucin Release
Airway mucus hypersecretion is one of the major clinical manifestations of patients suffering from various pulmonary diseases. However, no drugs are yet available to control airway mucus hypersecretion. For the past 15 years, a plethora of information has amassed with regard to the pharmacology of a...
Saved in:
Main Authors: | Kwang Chul Kim (Author), Akinori Hisatsune (Author), Do Jin Kim (Author), Takeshi Miyata (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2003-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Age-related decline in goblet cell numbers and mucin content of the human colon: Implications for lower bowel functions in the elderly
by: Nicholas Baidoo, et al.
Published: (2024) -
Goblet Cell Carcinoid of the Rectum in a Patient with Neurofibromatosis Type 1
by: Youngjin Kang, et al.
Published: (2016) -
Modulation of Conjunctival Goblet Cell Function by Inflammatory Cytokines
by: L. Contreras-Ruiz, et al.
Published: (2013) -
Role of Goblet Cells in Intestinal Barrier and Mucosal Immunity
by: Yang S, et al.
Published: (2021) -
Case of mucinous adenocarcinoma of the lung associated with congenital pulmonary airway malformation in a neonate
by: Juneyoug Koh, et al.
Published: (2018)